12-HETE	12-Hydroxy-5,8,10,14-eicosatetraenoic acid
AbsC	Absolute configuration
ABTS	2,2′-Azino-bis(3-ethylbenzothiozoline-6-sulfonic acid) diammonium salt
AChE	Acetylcholinesterase
BChE	Butyrylcholinesterase
CC	Column chromatography
CDA	Chiral derivatizing agent
CHS	Chalcone synthase
COSY	Correlation spectroscopy
COX	Cyclooxygenase
DEPT	Distortion enhancement by polarization transfer
DPPH	2,2-Diphenyl-1-picrylhydrazyl
EC50	Half maximal effective concentration
ECD	Electronic circular dichroism
GIAO	Gauge-independent atomic orbital
GPC	Gel permeation chromatography
HHT	12-Hydroxy-5,8,10-heptadecatrienoic acid
HIV-1	Human immunodeficiency virus type 1
HMBC	Heteronuclear multiple bond correlation
IC50	Half maximal inhibitory concentration
iNOS	Inducible nitric oxide synthase
KS	Kaposi’s sarcoma
LLE	Liquid–liquid extraction
LOX	Lipoxygenase
LPS	Lipopolysaccharide
LTB4	Leukotriene B4
MAPK	Mitogen-activated protein kinases
MIC	Minimum inhibitory concentration
MPLC	Medium-pressure liquid chromatography
MTPA	α-methoxy-α-trifluoromethylphenylacetic acid
MTT	3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide
NF-κB	Nuclear factor kappa-light-chain-enhancer of activated B cells
NMR	Nuclear magnetic resonance
NO	Nitric oxide
NOESY	Nuclear Overhauser effect spectroscopy
NOR 1	(±)-(E)-Methyl-2-[(E)-hydroxyimino]-5-nitro-6-methoxy-hex-3-enamide
NP	Normal phase
PAF	Platelet-activating factor
PARP-1	Poly(ADP-ribose) polymerase 1
PGE2	Prostaglandin E2
PLC	Preparative thin-layer chromatography
PTP1B	Human protein tyrosine phosphatase 1B
QM	Quantum mechanical
RelC	Relative configuration
ROS	Reactive oxygen species
RP	Reversed phase
STS	Stilbene synthase
TDDFT	Time-Dependent Density-Functional Theory
TEAC	Trolox Equivalent Antioxidant Capacity
THMS	trans-3,3′,5,5′-Tetrahydroxy-4′-methoxystilbene
TLC	Thin-layer chromatography
TNF-α	Tumor necrosis factor-α
UV/Vis	Ultraviolet/Visible
VCD	Vibrational circular dichroism
VEGF	Vascular endothelial growth factor
XRD	X-ray diffraction